Open Access
Subscription or Fee Access
Concise Review on Pharmacological Interventions in Diabetes: Impediment and Treatment
Abstract
Purpose about review: Diabetes is related with metabolic condition which is growing rapidly nowadays. The main reason behind the disease is autoimmune devastation of pancreatic beta cells that lead the impair action of the insulin on the tissues. Recent findings: Synthetic medications have various adverse drug reactions as well as treatment of cost is high. Consequently, herbal medicines have rising interest and gowning to replace the synthetic medications currently. Inference: This review delivers an outline of the complications and possible treatment for diabetes with brief knowledge. Moreover, the review tries to discuss upcoming herbal plants to treat this metabolic disorder.
References
Nabi AN, Ebihara A. Diabetes and Renin-Angiotensin-Aldosterone System: Pathophysiology and Genetics. In: Renin-Angiotensin Aldosterone System. InTech Open; 2021. https://doi.org/10.5772/intechopen.97518.
Lucier J, Weinstock RS. Diabetes Mellitus Type 1. 2022 Jun 9. In: StatPearls [Online]. Treasure Island (FL): StatPearls Publishing; 2022 Jan. PMID: 29939535.
Olokoba Abdulfatai B, Obateru Olusegun A, Olokoba Lateefat B. Type 2 Diabetes Mellitus: A Review of Current Trends. Oman Med J. 2012; 27(4): 269–273. DOI 10. 5001/omj.2012.68.
Kharroubi AT, Darwish HM. Diabetes mellitus: The epidemic of the century. World J Diabetes.2015 Jun 25; 6(6): 850–67. doi: 10.4239/wjd. v6.i6.850.
Wang Yaqi, Yang Peiyuan, Yan Zhaoli, Liu Zhi, Ma Qiang, Zhang Zehong, Wang Yunxia, Su Yan. The Relationship between Erythrocytes and Diabetes Mellitus, and to monitor the therapeutic effect of diabetes mellitus. J Diabetes Res. 2021 Feb 26; 2021: 6656062.
https://doi.org/10.1155/2021/6656062, 10.1155/2021/6656062.
Atkinson MA, Eisenbarth GS, Michels AW. Type 1 diabetes. Lancet. 2014 Jan 4; 383(9911): 69–82. doi: 10.1016/S0140-6736(13)60591-7
Deshpande AD, Harris-Hayes M, Schootman M. Epidemiology of Diabetes and Diabetes-Related Complications. Phys Ther. 2008; 88(11): 1254–1264. doi:10.2522/ptj.20080020.8.
Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO
consultation. Diabet Med. 1998 Jul; 15(7): 539–53. doi: 10.1002/(SICI)1096-9136(199807)15:7
Schalkwijk CG, Ligtvoet N, Twaalfhoven H, Jager A, Blaauwgeerset H, et al. Amadori albumin in type 1 diabetic patients: correlation with markers of endothelial function, association with diabetic nephropathy, and localization in retinal capillaries. Diabetes. 1999; 48(12): 2446–2453.
Langlais PR, Mandarino LJ, Timothy Garvey W. Mechanisms of insulin signal transduction. International Textbook of Diabetes Mellitus. Wiley; 2015; 161–192. doi:10.1002/9781118387658.ch12.
Papatheodorou Konstantinos, Banach Maciej, Michael Edmonds, Papanas Nikolaos, Papazoglou Dimitrios. Complications of Diabetes. J Diabetes Res. 2015; 2015: 189525. https://doi.org/10.1155/2015/189525, 10.1155/2015/189525.
Rosenberger DC, Blechschmidt V, Timmerman H, et al. Challenges of neuropathic pain: focus on diabetic neuropathy. J Neural Transm. 2020; 127(4): 589–624. https://doi.org/10.1007/s00702-020-02145-7.
Gylfadottir SS, Christensen DH, Nicolaisen SK, Andersen H, Callaghan BC, Itani M, Khan KS, Kristensen AG, Nielsen JS, Sindrup SH, Andersen NT, Jensen TS, Thomsen RW, Finnerup NB. Diabetic polyneuropathy and pain, prevalence, and patient characteristics: a cross-sectional
questionnaire study of 5,514 patients with recently diagnosed type 2 diabetes. Pain. 2020 Mar;161(3): 574–583. doi:10.1097/j.pain.0000000000001744.
Schreiber AK. Diabetic neuropathic pain: Physiopathology and treatment. World J Diabetes. 2015;6(3): 432–444. doi:10.4239/wjd.v6.i3.432.
La Sala L, Prattichizzo F, Ceriello A. The link between diabetes and atherosclerosis. Eur J Prev Cardiol. 2019; 26(2_suppl): 15–24. doi: 10.1177/2047487319878373.
Aronson D, Rayfield EJ. How hyperglycemia promotes atherosclerosis: molecular mechanisms. Cardiovasc Diabetol. 2002; 1: 1. https://doi.org/10.1186/1475-2840-1-1.
Beckman JA, Creager MA, Libby P. Diabetes and Atherosclerosis. JAMA. 2002; 287(19): 2570–81. doi:10.1001/jama.287.19.2570.
Mirella Hage, Zantout Mira S, Azar Sami T. Thyroid Disorders and Diabetes Mellitus. J Thyroid Res. 2011; 2011: Article ID 439463. https://doi.org/10.4061/2011/439463.
Kalra S, Aggarwal S, Khandelwal D. Thyroid Dysfunction and Type 2 Diabetes Mellitus: Screening Strategies and Implications for Management. Diabetes Ther. 2019 Dec; 10(6): 2035–2044. doi:10.1007/s13300-019-00700-4.
Mohammed Hussein S, Abd Elmageed R. The Relationship Between Type 2 Diabetes Mellitus and Related Thyroid Diseases. Cureus. 2021; 13(12): e20697. doi:10.7759/cureus.20697.
Bays HE, Chapman RH, Grandy S. The relationship of body mass index to diabetes mellitus, hypertension and dyslipidemia: comparison of data from two national surveys. Int J Clin Pract. 2007 May; 61(5): 737–47. doi: 10.1111/j.1742-1241.2007.01336.
Gray N, Picone G, Sloan F, Yashkin A. Relation between BMI and diabetes mellitus and its complications among US older adults. South Med J. 2015 Jan; 108(1): 29–36. doi:10.14423/SMJ.0000000000000214.
Andréasson Karin, Edqvist Jon, Adiels Martin, Björck Lena, Lindgren Martin, Sattar Naveed. Body mass index in adolescence, risk of type 2 diabetes and associated complications a nationwide cohort study of men. E-Clinical Medicine. 2022 Mar 21; 46: 101356. Doi https://doi.org/10.1016/j.eclinm.
Dove A, Marseglia A, Shang Y, Grande G, Vetrano DL, Laukka EJ, Fratiglioni L, Xu W. Cardiometabolic multimorbidity accelerates cognitive decline and dementia progression. Alzheimer’s Dement. 2022 Jun 16. doi: 10.1002/alz.12708.
Zilliox LA, Chadrasekaran K, Kwan JY, Russell JW. Diabetes and Cognitive Impairment. Curr Diab Rep. 2016 Sep; 16(9): 87. doi: 10.1007/s11892-016-0775-x.
Nabi AN, Ebihara A. Diabetes and Renin-Angiotensin-Aldosterone System: Pathophysiology and Genetics. In: Renin-Angiotensin-Aldosterone System. InTech Open; 2021. https://doi.org/10.5772/intechopen.97518.
Ribeiro-Oliveira A Jr, Nogueira AI, Pereira RM, Boas WW, Dos Santos RA, Simões e Silva AC. The renin-angiotensin system and diabetes: an update. Vasc Health Risk Manag. 2008; 4(4): 787–803.
Sagandira CR, Khasipo AZ, Sagandira MB, Watts P. An overview of the synthetic routes to essential oral anti-diabetes drugs. Tetrahedron. 2021; 96: 132378. doi: 10.1016/j.tet.2021.132378
Kooti W, Farokhipour M, Asadzadeh Z, Ashtary-Larky D, Asadi-Samani M. The role of medicinal plants in the treatment of diabetes: a systematic review. Electron Physician. 2016; 8(1): 832–42. doi: 10.19082/1832.
Ikiriza H, Ogwang PE, Peter EL, Hedmon O, Tolo CU, Abubaker M, Abdalla AAM. Dioscorea bulbifera, a highly threatened African medicinal plant, a review. Cogent Biol. 2019; 5(1): 1631561. doi:10.1080/23312025.2019.1631561.
Salehi B, Sener B, Kilic M, Sharifi-Rad J, Naz R, Yousaf Z, Mudau FN, Fokou PVT, Ezzat SM, El Bishbishy MH, Taheri Y, Lucariello G, Durazzo A, Lucarini M, Suleria HAR, Santini A. Dioscorea Plants: A Genus Rich in Vital Nutra-pharmaceuticals: A Review. Iran J Pharm Res. 2019; 18(Suppl1): 68–89. doi: 10.22037/ijpr.2019.112501.13795.
DOI: https://doi.org/10.37591/(rrjops).v13i3.1257
Refbacks
- There are currently no refbacks.
Copyright (c) 2023 Research and Reviews: A Journal of Pharmaceutical Science